Literature DB >> 32934407

Post-CPR scrub typhus patient with ARDS: A case report.

Ashish Minhas1, Nishchint Sharma2, Shalini Sharma2, Versha Verma2.   

Abstract

Entities:  

Year:  2020        PMID: 32934407      PMCID: PMC7457987          DOI: 10.4103/ija.IJA_204_20

Source DB:  PubMed          Journal:  Indian J Anaesth        ISSN: 0019-5049


× No keyword cloud information.
Sir, Scrub typhus is a zoonotic disease caused by Orientia tsutsugamushi confined to East Asia and the Western Pacific islands.[1] The case description includes a primary papular lesion, which enlarges, undergoes central necrosis, and crusts to form a flat black eschar. This is associated with regional and later generalised lymphadenopathy (enlarged and tender nodes). Despite antibiotic treatment, scrub typhus with severe complications rarely progresses to a fatal disease including sepsis and myocarditis. In the case of fulminant scrub typhus myocarditis, its complications can lead to cardiogenic shock and cardiac arrest. But it has rarely been reported. Here, we report a patient who was taken after hypoxic cardiac arrest and treated with open lung ventilation and was subsequently discharged. A 34-year-old female presented to our institution with symptoms of high-grade fever, chills, headache for 8 days followed by pedal oedema with shortness of breath. The patient was diagnosed with scrub typhus (eschar right side inguinal region) and acute respiratory distress syndrome (ARDS). On examination, peripheral capillary oxygen saturation (SPO2) and heart rate (HR) were not recordable; Glasgow coma scale showed E1V1M1, bilaterally chest crepts were present. The patient had deranged laboratory investigations [Figure 1]. Later, X-ray chest was done, bilateral chest infiltrates were present, and in serological test, IgM antibodies for scrub typhus were found.
Figure 1

Change in laboratory investigations from day-1 to day-9

Change in laboratory investigations from day-1 to day-9 The patient was intubated and cardiopulmonary resuscitation (CPR) started, inj. adrenaline was given; the patient revived and shifted to the intensive care unit (ICU) with noradrenaline infusion for further management. All standard monitoring was attached (opening vitals HR- 150/min, blood pressure- 74/44 mmHg, SPO268%, pupil dilated reactive to light). Infusions of dopamine and dobutamine were started and the patient was put on assisted-control mode-volume controlled ventilation (Acmv-Vcv) mode with the setting of tidal volume-300, respiratory rate- 24, positive end expiratory pressure (PEEP)-12 cm H2O, and the fraction of inspired oxygen-1 [Table 1]. Further PEEP was increased to 20 cm H2O with close monitoring of vitals. Lung protective strategies involve the use of higher respiratory rate, lower tidal volume (48 mL/kg predicted body weight) to achieve the minute ventilation and for improvement of oxygenation; we require higher PEEP with targeted plateau pressure <30 cm H2O to meet pH goal of 7.30 to 7.45 and to prevent barotrauma.[23] The patient was sedated with midazolam infusion to prevent dyssynchrony.
Table 1

Ventilation parameters during the course of hospital stay

ACMV-VCVACMV-PCVACMV-PCVACMV-PCVACMV-PCVACMV-PCVACMV-PCVSIMV-PCVSPONT
TV300--------
RR2422221816161412-
PEEP2018181210101085
PSV-------1410
FiO2110.70.450.50.50.50.40.3
Day-1Day-2Day-3Day-4Day-5Day-6Day-7Day-8Day-9
PH7.3377.3317.3337.3727.497.3617.4967.5047.451
pco232.644.66360.746.461.533.133.635.5
PaO245.6586569.27068.4126.494.6161
HCO3172233.335.335.434.825.626.525
Lactate6.181.210.780.690.660.860.940.690.72
PaO2/FiO245.65890173140137252235536

ACMV-VCV=Assisted-control mode ventilation-volume-control ventilation, PCV=Pressure-control ventilation, SIMV=Synchronised intermittent mandatory ventilation, TV=Tidal volume, RR=Respiratory rate, PEEP=Positive end expiratory pressure, PSV=Pressure support ventilation, FiO2=Fraction of inspired oxygen, pH=Potential of hydrogen, pCO2=Partial pressure of carbon dioxide, PaO2=Partial pressure of oxygen, HCO3=Bicarbonate

Ventilation parameters during the course of hospital stay ACMV-VCV=Assisted-control mode ventilation-volume-control ventilation, PCV=Pressure-control ventilation, SIMV=Synchronised intermittent mandatory ventilation, TV=Tidal volume, RR=Respiratory rate, PEEP=Positive end expiratory pressure, PSV=Pressure support ventilation, FiO2=Fraction of inspired oxygen, pH=Potential of hydrogen, pCO2=Partial pressure of carbon dioxide, PaO2=Partial pressure of oxygen, HCO3=Bicarbonate The patient was started on tablet doxycycline 100 mg bd, inj. azithromycin 500 mg od, tab. rifampicin 600 mg od, inj. pantoprazole 40 mg od, inj. ondansetron 4 mg tid, inj. hydrocortisone 100 mg tid, and inj. paracetamol 1 gm tid. The condition of the patient improved day by day and the patient was extubated on 26/10/2017 and discharged from ICU on 28/10/2017. Severity varies from subclinical illness to severe illness with multiple organ system involvements, which can be serious enough to be fatal unless diagnosed early and treated. Serious complications of scrub typhus are not uncommon and may be fatal; they include pneumonia, myocarditis, meningo-encephalitis, acute renal failure, and gastrointestinal bleeding. Patients with scrub typhus and presenting with multiorgan dysfunction syndrome may end in mortality.[4] Doxycycline 200 mg/day is the treatment of choice for scrub typhus.[56] Other antibiotics useful for the treatment of this infection are chloramphenicol, azithromycin and rifampicin. Rapid resolution of fever following doxycycline is so characteristic that it can be used as a therapeutic test. In this case, the patient presented very late on 8th day of fever with ARDS and had a hypoxic cardiac arrest in the initial examination. We found the eschar in the patient and started the treatment. The patients with ARDS require mechanical ventilation support, and we were able to save the patient with the help of mechanical ventilation. Early diagnosis and treatment with the support of mechanical ventilation is the key to survival.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  6 in total

1.  Profile of organ dysfunction and predictors of mortality in severe scrub typhus infection requiring intensive care admission.

Authors:  Mathew Griffith; John Victor Peter; Gunasekaran Karthik; Kartik Ramakrishna; John Antony Jude Prakash; Rajamanickam C Kalki; George M Varghese; Anugragh Chrispal; Kishore Pichamuthu; Ramya Iyyadurai; Ooriapadickal Cherian Abraham
Journal:  Indian J Crit Care Med       Date:  2014-08

2.  COVID Operation Theatre- Advisory and Position Statement of Indian Society of Anaesthesiologists (ISA National).

Authors:  Naveen Malhotra; Sukhminder Jit Singh Bajwa; Muralidhar Joshi; Lalit Mehdiratta; Anjan Trikha
Journal:  Indian J Anaesth       Date:  2020-05-01

Review 3.  Antibiotics for treating scrub typhus.

Authors:  Iman El Sayed; Qin Liu; Ian Wee; Paul Hine
Journal:  Cochrane Database Syst Rev       Date:  2018-09-24

4.  Peri-operative and critical care concerns in coronavirus pandemic.

Authors:  Sukhminder Jit Singh Bajwa; Rashi Sarna; Chashamjot Bawa; Lalit Mehdiratta
Journal:  Indian J Anaesth       Date:  2020-03-28

Review 5.  A Review of Scrub Typhus (Orientia tsutsugamushi and Related Organisms): Then, Now, and Tomorrow.

Authors:  Alison Luce-Fedrow; Marcie L Lehman; Daryl J Kelly; Kristin Mullins; Alice N Maina; Richard L Stewart; Hong Ge; Heidi St John; Ju Jiang; Allen L Richards
Journal:  Trop Med Infect Dis       Date:  2018-01-17

6.  Mortality due to scrub typhus - report of five cases.

Authors:  Rama Chaudhry; Chandan Kumar Thakur; Nitin Gupta; Tanu Sagar; Tej Bahadur; Naveet Wig; Rita Sood; Mahesh Chandra Misra
Journal:  Indian J Med Res       Date:  2019-06       Impact factor: 2.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.